Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of pemirolast effects on hs-CRP in coronary artery disease
2009-016823-74Phase 2Terminated
- Sponsor
- Cardoz
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pemirolast in coronary arteriosclerosis, sponsored by Cardoz. Primary endpoint: Change in hs-CRP. Started Nov 2009; status: terminated.
02
Drugs
pemirolast
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2009-016823-74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016823-74.